These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7194081

  • 1. [Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research].
    Beck OA, Spielmann H, Witt E, Oeff M, Liddard C, Hochrein H.
    Arzneimittelforschung; 1980; 30(12):2172-81. PubMed ID: 7194081
    [Abstract] [Full Text] [Related]

  • 2. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J, Klein H, Shanks RG, Bender F.
    Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
    [Abstract] [Full Text] [Related]

  • 3. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M.
    Schweiz Med Wochenschr; 1984 Jan 21; 114(3):77-86. PubMed ID: 6199838
    [Abstract] [Full Text] [Related]

  • 4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 21; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
    Malpartida F, Triola M, Huguet R, Sala J, Noguera J, Cordeiro B.
    Rev Med Univ Navarra; 1975 Oct 21; 19(1):143-9. PubMed ID: 1234780
    [Abstract] [Full Text] [Related]

  • 6. [Antiarrhythmic effect of propafenone in relation to serum concentration and conduction time (author's transl)].
    Meyer-Estorf G, Keller K, Beck OA, Hochrein H.
    Z Kardiol; 1978 May 21; 67(5):353-6. PubMed ID: 654420
    [Abstract] [Full Text] [Related]

  • 7. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA, Ivanova LA, Pavlova TS.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986 May 21; 9(2):30-3. PubMed ID: 3541962
    [Abstract] [Full Text] [Related]

  • 8. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA, Campos Peris JV, García García J, Jaen Armand E, Ruiz Ros JA, Salas Nieto J, Rodríguez Ruiz P, Marco Quiles J, Martínez Jérez M, Pico Aracil F.
    Arch Inst Cardiol Mex; 1981 May 21; 51(4):371-6. PubMed ID: 7337481
    [Abstract] [Full Text] [Related]

  • 9. [Assessment of anti-arrhythmic efficacy of a domestic drug allapinin in patients with ischemic heart disease and cardiac arrhythmia].
    Zamotaev IuN, Kremnev IuA, Grinenko NA, Podshibiakin SE.
    Klin Med (Mosk); 2003 May 21; 81(11):51-4. PubMed ID: 14689712
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H, Stroobandt R.
    Arch Int Pharmacodyn Ther; 1977 Dec 21; 230(2):225-34. PubMed ID: 603318
    [Abstract] [Full Text] [Related]

  • 11. [Oral therapy of ectopic cardiac arrhythmias with Propafenon (author's transl)].
    Beck OA, Abdulla S, Hochrein H.
    Med Klin; 1975 Oct 17; 70(42):1713-6. PubMed ID: 52828
    [Abstract] [Full Text] [Related]

  • 12. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF, Golitsyn SP, Malakhov VI, Bankuzov VA, Koltunova MI, Golitsyn LS.
    Farmakol Toksikol; 1990 Oct 17; 53(3):57-60. PubMed ID: 2387385
    [Abstract] [Full Text] [Related]

  • 13. [Long-term treatment with the new antiarrhythmic drug propafenone in correlation to plasma levels (author's transl)].
    Wiebringhaus E, Seipel L, Breithardt G, Loogen F.
    Z Kardiol; 1977 Nov 17; 66(11):625-32. PubMed ID: 22958
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H.
    J Cardiovasc Pharmacol; 1994 Mar 17; 23(3):374-8. PubMed ID: 7515979
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
    Saitta A, Bonaiuto M, Mileto A, Oriti S, Cinquegrani M, Giordano G, Fodale P, Saitta M, Squadrito F.
    Clin Ter; 1993 Apr 17; 142(4):351-60. PubMed ID: 8330479
    [Abstract] [Full Text] [Related]

  • 16. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G, Capucci A, Strocchi E, Calliva R, Santarelli A, Biffi M, Magnani B.
    Int J Clin Pharmacol Res; 1993 Apr 17; 13(4):211-9. PubMed ID: 8150547
    [Abstract] [Full Text] [Related]

  • 17. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL, Lechat P, Frank R, Lascault G, Fontaine G, Facquet J, Cohen A, Grosgogeat Y.
    Ann Cardiol Angeiol (Paris); 1984 Apr 17; 33(5):309-15. PubMed ID: 6476769
    [Abstract] [Full Text] [Related]

  • 18. [Dangerous arrhythmias].
    Gertsch M, Fuhrer J.
    Schweiz Med Wochenschr; 1993 May 01; 123(17):833-43. PubMed ID: 8497770
    [Abstract] [Full Text] [Related]

  • 19. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP.
    Arch Mal Coeur Vaiss; 1995 Dec 01; 88(12):1869-74. PubMed ID: 8729368
    [Abstract] [Full Text] [Related]

  • 20. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L, Abendroth RR, Breithardt G.
    Z Kardiol; 1981 Jul 01; 70(7):524-9. PubMed ID: 7269731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.